Controversies in Persistent (Chronic) Lyme Disease.
Elizabeth L Maloney
PMID 27755213WHAT IT FOUND
Post-treatment Lyme symptoms are real and often disabling, but ongoing infection cannot be confirmed by serology.
The review argues for careful, patient-centered decisions about retreatment and monitoring. Infusion nurses can support education, advocacy, and shared decision making.
Key findings
01The review argues that symptoms persisting after Lyme disease treatment are not merely ordinary complaints or automatically another condition.
02Serologic testing cannot determine whether a treated Lyme disease patient has ongoing infection.
03Infusion nurses can support shared decision making, patient education, and monitoring of treatment response.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review, not a new trial or systematic review, so it does not establish effect sizes or a definitive treatment protocol. The author selects and interprets cited evidence, and the paper itself states that the science is uncertain and contested. It does not report original patient outcomes or test nursing interventions. Claims about retreatment benefit and risk come from cited studies with differing designs and selected patient groups.
Declared interests
The author states no conflicts of interest to disclose.
The easy way to misread this
Do not conclude that persistent Lyme disease is proven chronic infection requiring routine IV antibiotics. The review says serology cannot confirm ongoing infection, and retreatment may help only selected patients while serious adverse events were reported.